Cite
HARVARD Citation
Howard, J. et al. (2023). Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. Lancet neurology. 22 (5), pp. 395-406. [Online].